A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor)
Clinical trial NCT06277752 · COMPLETED
Trial details
- NCT number
- NCT06277752
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-05
- Primary completion
- 2024-03-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.